跳至主要内容
临床试验/ISRCTN63283043
ISRCTN63283043已完成未知

urse-facilitated Adherence Therapy for Haemophilia (AnTHem Trial): a cluster randomised controlled trial

Canterbury Christ Church University (UK)0 个研究点目标入组 158 人开始时间: 2014年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
158

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Patients with Haemophilia A or B being treated at one of the 10 haemophilia comprehensive care centres included in the trial
  • 2. Aged 12 years or over who have been self-infusing clotting factor for a minimum of 6 months
  • 3. Able to provide informed consent (or able to consent with parental/guardian agreement and signature)
  • 4. With identified nonadherence issues (as determined by a score of =57 on the VERITASpro assessment measure)
  • 5. English speaking and literate to a degree necessary to understand the PIS and the VERITASpro assessment measure and to complete the AnTHem workbook

排除标准

  • 1. Patients that do not meet the abovementioned criteria
  • 2. Patients identified as having nontransient inhibitors to factor VIII or IX
  • 3. Patients who during the period of the research develop nontransient inhibitors to factor VIII or IX

研究者

发起方
Canterbury Christ Church University (UK)

相似试验